An increasingly intense competitive environment and the shrinking pools of treatment populations in traditional markets has forced drug companies to ‘go global’ and approach emerging markets to place research and secure enrollment. But how do you ‘go global’ without sacrificing consistency and quality in clinical trials?
This audio conference discusses the unique challenges posed by international clinical trials, and provide a regulatory expert view of how to overcome these challenges and ensure compliance across various countries and geographic regions.
Ensuring Compliance in Global Clinical Trials was presented by Bruce Wagman, Vice President Regulatory & QA Services, with Covance, Inc. and aired on 2008-04-24. For more details or to download this conference, please visit our site at www.fxconferences.com
